Serum cholesterol levels and cancer mortality in 361662 men screneed for the multiple risk factor intervention trial
Sherwin, R.W.; Wentworth, D.N.; Cutler, J.A.; Hulley, S.B.; Kuller, L.H.; Stamler, J.
Jama, the Journal of the American Medical Association 257(7): 943-948
1987
ISSN/ISBN: 0098-7484 Accession: 077749871
Full Text Article emailed within 1 workday: $29.90
Related References
Sherwin, R.W.; Wentworth, D.N.; Cutler, J.A.; Hulley, S.B.; Kuller, L.H.; Stamler, J. 1987: Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial JAMA 257(7): 943-948Sherwin, R.W.; Wentworth, D.N.; Cutler, J.A.; Hulley, S.B.; Kuller, L.H.; Stamler, J. 1987: Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention Trial JAMA 257(7): 943-948
Iso, H.; Jacobs, D.R.; Wentworth, D.; Neaton, J.D.; Cohen, J.D. 1989: Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial New England Journal of Medicine 320(14): 904-910
Neaton, J.D.; Blackburn, H.; Jacobs, D.; Kuller, L.; Lee, D.J.; Sherwin, R.; Shih, J.; Stamler, J.; Wentworth, D. 1992: Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group Archives of Internal Medicine 152(7): 1490-1500
Neaton, J.D.; Blackburn, H.; Jacobs, D.; Kuller, L.; Duckjoo, L.E.E.; Sherwin, R.; Shih, J.; Stamler, J.; Wentworth, D. 1992: Serum cholesterol level and mortality findings for men screened in the multiple risk factor intervention trial Archives of Internal Medicine 152(7): 1490-1500
1990: Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group JAMA 263(13): 1795-1801
Christakis, G.; Wilcox, M. 1979: Serum cholesterol changes in 6000 multiple risk factor intervention trial participants after 2 years of intervention Federation Proceedings 38(3 Part 1): 446
1985: Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group American Journal of Cardiology 55(1): 1-15
1982: Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group JAMA 248(12): 1465-1477
Shaten, B.J.; Kuller, L.H.; Kjelsberg, M.O.; Stamler, J.; Ockene, J.K.; Cutler, J.A.; Cohen, J.D. 1997: Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups. Multiple Risk Factor Intervention Trial Annals of Epidemiology 7(2): 125-136
Kuller, L.H.; Eichner, J.E.; Orchard, T.J.; Grandits, G.A.; McCallum, L.; Tracy, R.P. 1991: The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial American Journal of Epidemiology 134(11): 1266-1277
Stamler, J.; Wentworth, D.; Neaton, J.D. 1986: Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT) JAMA 256(20): 2823-2828
Suh, I.; Shaten, B.J.; Cutler, J.A.; Kuller, L.H. 1992: Alcohol use and mortality from coronary heart disease: the role of high-density lipoprotein cholesterol. the Multiple Risk Factor Intervention Trial Research Group Annals of Internal Medicine 116(11): 881-887
Coughlin, S.S.; Neaton, J.D.; Randall, B.; Sengupta, A. 1997: Predictors of mortality from kidney cancer in 332,547 men screened for the Multiple Risk Factor Intervention Trial Cancer 79(11): 2171-2177
Kuller, L.; Farrier, N.; Caggiula, A.; Borhani, N.; Dunkle, S. 1985: Relationship of diuretic therapy and serum magnesium levels among participants in the Multiple Risk Factor Intervention Trial American Journal of Epidemiology 122(6): 1045-1059
Hulley, S.; Ashman, P.; Kuller, L.; Lasser, N.; Sherwin, R. 1979: HDL-cholesterol levels in the Multiple Risk Factor Intervention Trial (MRFIT) by the MRFIT Research Group 1,2 Lipids 14(1): 119-123
Simon, J.A.; Fong, J.; Bernert, J.T.; Browner, W.S. 1998: Serum fatty acids and the risk of fatal cancer. MRFIT Research Group. Multiple Risk Factor Intervention Trial American Journal of Epidemiology 148(9): 854-858
Cohen, J.D.; Eberly, L.E.; Huang, R.; Prineas, R. 2002: Mean fasting glucose levels incrementally predict cardiovascular disease mortality Eighteen year follow-up in the multiple risk factor intervention trial Circulation 106(19): II508
Leon, A.S.; Connett, J. 1989: Physical activity and 105 year mortality from cardiovascular diseases cvd cancer and all causes in the multiple risk factor intervention trial mrfit Medicine and Science in Sports and Exercise 21(2 Suppl): S49
Kuller, L.H.; Ockene, J.; Meilahn, E.; Svendsen, K.H. 1990: Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the Multiple Risk Factor Intervention Trial (MRFIT) American Journal of Epidemiology 132(2): 265-274